Literature DB >> 23804563

The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures.

Catharine E Krebs1, Siamak Karkheiran, James C Powell, Mian Cao, Vladimir Makarov, Hossein Darvish, Gilbert Di Paolo, Ruth H Walker, Gholam Ali Shahidi, Joseph D Buxbaum, Pietro De Camilli, Zhenyu Yue, Coro Paisán-Ruiz.   

Abstract

This study aimed to elucidate the genetic causes underlying early-onset Parkinsonism (EOP) in a consanguineous Iranian family. To attain this, homozygosity mapping and whole-exome sequencing were performed. As a result, a homozygous mutation (c.773G>A; p.Arg258Gln) lying within the NH2 -terminal Sac1-like inositol phosphatase domain of polyphosphoinositide phosphatase synaptojanin 1 (SYNJ1), which has been implicated in the regulation of endocytic traffic at synapses, was identified as the disease-segregating mutation. This mutation impaired the phosphatase activity of SYNJ1 against its Sac1 domain substrates in vitro. We concluded that the SYNJ1 mutation identified here is responsible for the EOP phenotype seen in our patients probably due to deficiencies in its phosphatase activity and consequent impairment of its synaptic functions. Our finding not only opens new avenues of investigation in the synaptic dysfunction mechanisms associated with Parkinsonism, but also suggests phosphoinositide metabolism as a novel therapeutic target for Parkinsonism.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  SYNJ1; autosomal recessive Parkinsonism; homozygosity mapping; whole-exome sequencing

Mesh:

Substances:

Year:  2013        PMID: 23804563      PMCID: PMC3790461          DOI: 10.1002/humu.22372

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  52 in total

Review 1.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

Review 2.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

3.  Regulation of postsynaptic AMPA responses by synaptojanin 1.

Authors:  Liang-Wei Gong; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

Review 4.  Synaptic vesicle trafficking and Parkinson's disease.

Authors:  Giovanni Esposito; Fernandes Ana Clara; Patrik Verstreken
Journal:  Dev Neurobiol       Date:  2012-01       Impact factor: 3.964

5.  Performance of mutation pathogenicity prediction methods on missense variants.

Authors:  Janita Thusberg; Ayodeji Olatubosun; Mauno Vihinen
Journal:  Hum Mutat       Date:  2011-02-22       Impact factor: 4.878

6.  LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.

Authors:  Samer Matta; Kristof Van Kolen; Raquel da Cunha; Geert van den Bogaart; Wim Mandemakers; Katarzyna Miskiewicz; Pieter-Jan De Bock; Vanessa A Morais; Sven Vilain; Dominik Haddad; Lore Delbroek; Jef Swerts; Lucía Chávez-Gutiérrez; Giovanni Esposito; Guy Daneels; Eric Karran; Matthew Holt; Kris Gevaert; Diederik W Moechars; Bart De Strooper; Patrik Verstreken
Journal:  Neuron       Date:  2012-09-20       Impact factor: 17.173

7.  The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals.

Authors:  Meera Mani; Sang Yoon Lee; Louise Lucast; Ottavio Cremona; Gilbert Di Paolo; Pietro De Camilli; Timothy A Ryan
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

8.  Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses.

Authors:  Sang Yoon Lee; Markus R Wenk; Yong Kim; Angus C Nairn; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

Review 9.  The genetics of Parkinson's syndromes: a critical review.

Authors:  John Hardy; Patrick Lewis; Tamas Revesz; Andrew Lees; Coro Paisan-Ruiz
Journal:  Curr Opin Genet Dev       Date:  2009-05-04       Impact factor: 5.578

10.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

View more
  125 in total

1.  Systematic Genetic Analysis of the SMPD1 Gene in Chinese Patients with Parkinson's Disease.

Authors:  Sheng Deng; Xiong Deng; Zhi Song; Xiaofei Xiu; Yi Guo; Jingjing Xiao; Hao Deng
Journal:  Mol Neurobiol       Date:  2015-09-16       Impact factor: 5.590

2.  Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline.

Authors:  Katia Hardies; Yiying Cai; Claude Jardel; Anna C Jansen; Mian Cao; Patrick May; Tania Djémié; Caroline Hachon Le Camus; Kathelijn Keymolen; Tine Deconinck; Vikas Bhambhani; Catherine Long; Samin A Sajan; Katherine L Helbig; Arvid Suls; Rudi Balling; Ingo Helbig; Peter De Jonghe; Christel Depienne; Pietro De Camilli; Sarah Weckhuysen
Journal:  Brain       Date:  2016-07-19       Impact factor: 13.501

3.  Genome-wide assessment of Parkinson's disease in a Southern Spanish population.

Authors:  Sara Bandrés-Ciga; Timothy Ryan Price; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Javier Pelegrina; Sampath Arepalli; Dena Hernández; Blanca Gutiérrez; Jorge Cervilla; Margarita Rivera; Alberto Rivera; Jing-Hui Ding; Francisco Vives; Michael Nalls; Andrew Singleton; Raquel Durán
Journal:  Neurobiol Aging       Date:  2016-06-11       Impact factor: 4.673

4.  Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice.

Authors:  Ping-Yue Pan; Patricia Sheehan; Qian Wang; Xinyu Zhu; Yuanxi Zhang; Insup Choi; Xianting Li; Jacqueline Saenz; Justin Zhu; Jing Wang; Farida El Gaamouch; Li Zhu; Dongming Cai; Zhenyu Yue
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 5.  Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Maria Nguyen; Yvette C Wong; Daniel Ysselstein; Alex Severino; Dimitri Krainc
Journal:  Trends Neurosci       Date:  2018-11-30       Impact factor: 13.837

Review 6.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

7.  PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family.

Authors:  Simone Olgiati; Anna De Rosa; Marialuisa Quadri; Chiara Criscuolo; Guido J Breedveld; Marina Picillo; Sabina Pappatà; Mario Quarantelli; Paolo Barone; Giuseppe De Michele; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2014-05-10       Impact factor: 2.660

8.  PTRHD1 (C2orf79) mutations lead to autosomal-recessive intellectual disability and parkinsonism.

Authors:  Hamidreza Khodadadi; Luis J Azcona; Vajiheh Aghamollaii; Mir Davood Omrani; Masoud Garshasbi; Shaghayegh Taghavi; Abbas Tafakhori; Gholam Ali Shahidi; Javad Jamshidi; Hossein Darvish; Coro Paisán-Ruiz
Journal:  Mov Disord       Date:  2016-10-18       Impact factor: 10.338

Review 9.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

Review 10.  Endosomal sorting pathways in the pathogenesis of Parkinson's disease.

Authors:  Lindsey A Cunningham; Darren J Moore
Journal:  Prog Brain Res       Date:  2020-03-16       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.